Hannah G King

发表

Redesigned HIV antibodies exhibit enhanced neutralizing potency and breadth.

Jens Meiler, James E Crowe, David C Montefiori, 2015, The Journal of clinical investigation.

Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection

James E. Crowe, Andrew B. Ward, Marnie L. Fusco, 2016, Cell.

Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth

Noah T. Ditto, N. Haigwood, D. Montefiori, 2018, PloS one.

Long antibody HCDR3s from HIV-naïve donors presented on a PG9 neutralizing antibody background mediate HIV neutralization

D. Montefiori, J. Meiler, J. Crowe, 2016, Proceedings of the National Academy of Sciences.

BROADLY NEUTRALIZING ANTIBODIES FROM HUMAN SURVIVORS TARGET A CONSERVED SITE IN THE EBOLA VIRUS GLYCOPROTEIN HR2/MPER REGION

J. Crowe, E. Saphire, D. Wright, 2018, Nature Microbiology.

Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion protein

J. Meiler, J. Crowe, W. Schief, 2016, Proceedings of the National Academy of Sciences.

Recognition of influenza H3N2 variant virus by human neutralizing antibodies.

R. Webby, J. Crowe, K. Edwards, 2016, JCI insight.

Long antibody HCDR3s from HIV-naïve donors presented on a PG9 neutralizing antibody background mediate HIV neutralization

Jordan R. Willis, D. Montefiori, J. Meiler, 2016, Proceedings of the National Academy of Sciences.

Recognition of influenza H3N2 variant virus by human neutralizing antibodies.

R. Webby, J. Crowe, K. Edwards, 2016, JCI insight.

Redesigned HIV antibodies exhibit enhanced neutralizing potency and breadth.

Jordan R. Willis, I. Wilson, D. Montefiori, 2015, The Journal of clinical investigation.